FolaNAC: Triple Protection Against Memory Loss

According to the most recent (2021) Alzheimer’s Association statistics, more than 6 million Americans are living with Alzheimer’s disease (AD), the most common type of dementia. For most people, cognitive health and performance remain mostly stable over their lifetimes, with only a gradual decline in short-term memory and processing speed. For millions of others, on the […]